Haas Jason bought LGND
June 12, 2026 · Form 4 insider transaction
Haas Jason bought 1,000 shares of Ligand Pharmaceuticals Incorporated at $51.56 per share, a transaction worth $51.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,000
Price
$51.56
Total value
$51.6K
InsiderHaas Jason
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 12, 2026
Filing dateJune 15, 2026
Shares owned after11,442
OwnershipDirect
10b5-1 planNo
AmendedNo